AGXT p.Ser187Phe
c.560C>T · rs180177238 · VCV140584
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8329 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.928 | moderately pathogenic-leaning |
| SaProt | LLR -8.92 | tolerated |
| ⇒ AlphaMissense and REVEL call this damaging; SaProt does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.3 | GERP 0.98, phastCons 1 |
| Regional constraint | o/e 1.00 | unconstrained · MANE · 9,952 bp · p 0.92 · regional, not allelic |
| Overall | ||
| CADD | 24.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- AGXT
- Protein
- p.Ser187Phe
- Coding
- c.560C>T
- MANE Select
- NM_000030
- dbSNP
- rs180177238
- Type
- single nucleotide variant
- Location
- chr2:240873014 (GRCh38)
- Gene constraint
- LOEUF 1.251 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 98.30 · 17 PDB
- Residue 187
- a UniProt-annotated variant site (in hp1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization but improved dimerization in the presence of pyridoxal phosphate; decreased protein stability); a turn
Disease context
primary hyperoxaluria — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: primary hyperoxaluria type 1
For Primary hyperoxaluria (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- All ages
- Prevalence
- 1-9 / 1 000 000 (Germany)
Similar variants
- AGXT p.Ser187Tyr Conflicting classifications of pathogenicity ★ ⚠ same residue
- AGXT p.Ser187_Leu188insVal Pathogenic ★ same residue
- AGXT c.358+1G>A Pathogenic ★★ same condition
- AGXT c.359-2A>G Likely pathogenic ★★ same condition
- AGXT c.423+1G>A Pathogenic/Likely pathogenic ★★ same condition
- AGXT c.524+2T>A Likely pathogenic ★★ same condition
- AGXT c.525-1G>A Pathogenic ★★ same condition
- AGXT c.525-2A>T Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/agxt-p-ser187phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown